Does perimenopause cause irregular ovulation and abnormal uterine bleeding even with a normal single FSH test?

The perimenopausal transition is characterized by significant hormonal volatility and physiological shifts that frequently result in cycle irregularity and abnormal uterine bleeding, even when standard laboratory tests appear normal.

Clinical evidence and cycle dynamics

The transition into menopause is defined by a measurable decline in ovulatory consistency. Longitudinal data from the Study of Women's Health Across the Nation (SWAN) indicates that while anovulatory cycles (cycles where no egg is released) occur in roughly 20% of early perimenopausal cycles, this frequency increases to over 60% during the late transition. This shift leads to the hallmark symptoms of perimenopause:

• Cycle Irregularity: The timing of menstruation becomes unpredictable as the length of the follicular phase varies wildly.
• Abnormal Uterine Bleeding (AUB): The prevalence of AUB rises from roughly 12% in the general population to 24% during perimenopause. Clinical consensus identifies hormonal imbalances, rather than structural issues alone, as the primary driver of these erratic patterns.

Mechanistic explanations

The underlying cause of these symptoms is the dysregulation of the hypothalamic-pituitary-ovarian (HPO) axis as the ovarian follicle pool depletes.

• Progesterone Deficiency: In a normal cycle, ovulation triggers the formation of the corpus luteum, which produces progesterone. In anovulatory cycles, no corpus luteum forms, leading to a state of "unopposed estrogen."
• Endometrial Hyperplasia: Without progesterone to stabilize and eventually shed the uterine lining, estrogen continues to stimulate the endometrium to thicken. This results in unstable endometrial growth and unpredictable, often heavy, shedding (AUB).
• Erratic Feedback Loops: As the ovaries become less responsive, the pituitary gland increases follicle-stimulating hormone (FSH) production. However, the feedback loops are no longer consistent, leading to pulses of high estrogen followed by sudden drops, further destabilizing the cycle.

Diagnostic considerations

A single "normal" FSH measurement (typically 5–20 mIU/mL) does not rule out perimenopause. Because FSH levels fluctuate significantly from day to day and cycle to cycle during this transition, a one-time snapshot often misses the broader upward trajectory of the hormone. Leading clinical frameworks, such as the STRAW+10 and NICE guidelines, emphasize that perimenopause is a clinical diagnosis based on age-appropriate symptoms and persistent cycle changes rather than isolated laboratory values.

Bottom line

Perimenopause is characterized by increasingly inconsistent ovulation and "unopposed estrogen," which directly cause cycle irregularity and abnormal bleeding. Because of extreme hormonal volatility, a single normal FSH test is not a reliable indicator of reproductive status; diagnosis should instead focus on clinical symptoms and menstrual patterns.